In The Field

AACR: The return of cox-2 inhibitors

Today’s plenary session on ‘late-breaking clinical trials’ offered up a few new promising phase III trial results for the prevention of colorectal cancer. 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE